14 results on '"Robinson, Andrew"'
Search Results
2. Human tauopathy-derived tau strains determine the substrates recruited for templated amplification.
- Author
-
Tarutani, Airi, Miyata, Haruka, Nonaka, Takashi, Hasegawa, Kazuko, Yoshida, Mari, Saito, Yuko, Murayama, Shigeo, Robinson, Andrew C, Mann, David M A, Tomita, Taisuke, and Hasegawa, Masato
- Subjects
TAU proteins ,PROGRESSIVE supranuclear palsy ,FRONTOTEMPORAL lobar degeneration ,CHRONIC traumatic encephalopathy ,ALZHEIMER'S disease ,NEUROGLIA ,AMYLOID plaque ,BRAIN metabolism ,BRAIN ,RESEARCH ,NERVE tissue proteins ,NEURONS ,RESEARCH methodology ,EVALUATION research ,COMPARATIVE studies ,RESEARCH funding ,CELL lines ,NEURODEGENERATION - Abstract
Tauopathies are a subset of neurodegenerative diseases characterized by abnormal tau inclusions. Specifically, three-repeat tau and four-repeat tau in Alzheimer's disease, three-repeat tau in Pick's disease (PiD) and four-repeat tau in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) form amyloid-like fibrous structures that accumulate in neurons and/or glial cells. Amplification and cell-to-cell transmission of abnormal tau based on the prion hypothesis are believed to explain the onset and progression of tauopathies. Recent studies support not only the self-propagation of abnormal tau, but also the presence of conformationally distinct tau aggregates, namely tau strains. Cryogenic electron microscopy analyses of patient-derived tau filaments have revealed disease-specific ordered tau structures. However, it remains unclear whether the ultrastructural and biochemical properties of tau strains are inherited during the amplification of abnormal tau in the brain. In this study, we investigated template-dependent amplification of tau aggregates using a cellular model of seeded aggregation. Tau strains extracted from human tauopathies caused strain-dependent accumulation of insoluble filamentous tau in SH-SY5Y cells. The seeding activity towards full-length four-repeat tau substrate was highest in CBD-tau seeds, followed by PSP-tau and Alzheimer's disease (AD)-tau seeds, while AD-tau seeds showed higher seeding activity than PiD-tau seeds towards three-repeat tau substrate. Abnormal tau amplified in cells inherited the ultrastructural and biochemical properties of the original seeds. These results strongly suggest that the structural differences of patient-derived tau strains underlie the diversity of tauopathies, and that seeded aggregation and filament formation mimicking the pathogenesis of sporadic tauopathy can be reproduced in cultured cells. Our results indicate that the disease-specific conformation of tau aggregates determines the tau isoform substrate that is recruited for templated amplification, and also influences the prion-like seeding activity. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
3. Comparison of Common and Disease-Specific Post-translational Modifications of Pathological Tau Associated With a Wide Range of Tauopathies.
- Author
-
Kametani, Fuyuki, Yoshida, Mari, Matsubara, Tomoyasu, Murayama, Shigeo, Saito, Yuko, Kawakami, Ito, Onaya, Mitsumoto, Tanaka, Hidetomo, Kakita, Akiyoshi, Robinson, Andrew C., Mann, David M. A., and Hasegawa, Masato
- Subjects
FRONTOTEMPORAL lobar degeneration ,PROGRESSIVE supranuclear palsy ,POST-translational modification ,TAU proteins ,ALZHEIMER'S patients ,FRONTOTEMPORAL dementia - Abstract
Tauopathies are the most common type of neurodegenerative proteinopathy, being characterized by cytoplasmic aggregates of hyperphosphorylated tau protein. The formation and morphologies of these tau inclusions, the distribution of the lesions and related metabolic changes in cytoplasm differ among different tauopathies. The aim of this study was to examine whether there are differences in the post-translational modifications (PTMs) in the pathological tau proteins. We analyzed sarkosyl-insoluble pathological tau proteins prepared from brains of patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy, corticobasal degeneration, globular glial tauopathy, and frontotemporal dementia and parkinsonisms linked to chromosome 17 with tau inclusions using liquid chromatography mass spectrometry. In pathological tau proteins associated with a wide range of tauopathies, 170 PTMs in total were identified including new PTMs. Among them, common PTMs were localized in the N- and C-terminal flanking regions of the microtubule binding repeats and PTMs, which were considered to be disease-specific, were found in microtubule binding repeats forming filament core. These suggested that the differences in PTMs reflected the differences in tau filament core structures in each disease. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
4. Immunohistochemical detection of C9orf72 protein in frontotemporal lobar degeneration and motor neurone disease: patterns of immunostaining and an evaluation of commercial antibodies.
- Author
-
Davidson, Yvonne S., Robinson, Andrew C., Rollinson, Sara, Pickering-Brown, Stuart, Xiao, Shangxi, Robertson, Janice, and Mann, David M. A.
- Subjects
- *
IMMUNOSTAINING , *C9ORF72 gene , *FRONTOTEMPORAL lobar degeneration , *MOTOR neuron diseases , *AMYOTROPHIC lateral sclerosis - Abstract
We have employed as ‘gold standards’ two in-house, well-characterised and validated polyclonal antibodies, C9-L and C9-S, which detect the longer and shorter forms of C9orf72, and have compared seven other commercially available antibodies with these in order to evaluate the utility of the latter as credible tools for the demonstration of C9orf72. C9-L and C9-S antibodies immunostained cytoplasmic ‘speckles’, and the nuclear membrane, respectively, in cerebellar Purkinje cells of the cerebellum in patients with behavioural variant frontotemporal dementia (bvFTD) with amyotrophic lateral sclerosis (ALS), and in patients with ALS alone. Similar staining was seen in Purkinje cells in healthy control tissues and in other neurodegenerative disorders, and in pyramidal cells of CA4 and dentate gyrus of hippocampus. However, in the spinal cord there was little cytoplasmic staining with C9-L antibody. C9-S antibody immunostained the nuclear membrane of anterior horn cells in healthy neurons. In patients with bvFTD + ALS, or ALS alone, this C9-S nuclear staining was redistributed to the plasma membrane. In those patients with bvFTD + ALS or ALS bearing an expansion inC9orf72, none of the commercially available antibodies detected TDP-43 inclusions in anterior horn cells, nor were dipeptide repeat proteins demonstrated. Five of the commercial antibodies provided immunohistochemical staining patterns similar in morphological appearance to the in-house C9-L antibody, but distinct from C9-S antibody. However, only three showed sufficient specificity and intensity of staining for C9orf72 at acceptably low concentrations, to make them of practical value and sufficiently reliable for the detection of at least the longer form of C9orf72 protein. [ABSTRACT FROM PUBLISHER]
- Published
- 2018
- Full Text
- View/download PDF
5. Patterns of Microglial Cell Activation in Alzheimer Disease and Frontotemporal Lobar Degeneration.
- Author
-
Taipa, Ricardo, Brochado, Paulo, Robinson, andrew, Reis, Inês, Costa, Patrício, Mann, David M., Melo Pires, Manuel, and Sousa, Nuno
- Subjects
MICROGLIA ,ALZHEIMER'S disease ,FRONTOTEMPORAL lobar degeneration ,PATHOLOGICAL physiology ,MEMORY disorders - Abstract
Aims: Microglia-driven neuroinflammation can play an important role in the pathophysiology of neurodegenerative disorders. In this study, we sought to characterize the distribution of microglial cell activation in 2 neurodegenerative dementias with distinct protein signatures, Alzheimer disease (AD) and frontotemporal lobar degeneration (FTLD) of the TDP subtype, and to determine if there was an anatomical correlation with the phenotypes most commonly associated with these conditions. Methods: The distribution and extent of microglial cell activation was assessed semiquantitatively in the hippocampal formation, cortical gray matter, and subcortical white matter of CD68-immunostained sections of the frontal, temporal, parietal, and occipital cortices from 15 pathologically confirmed cases of AD, 13 cases of FTLD, and 18 controls. Results: Significantly higher levels of microglial cell activation occurred in the subiculum in AD and FTLD than in controls. Additionally, AD had higher microglial activation in the CA1 and FTLD in the hippocampal white matter than the controls. Microglial activation was greater in the dentate gyrus molecular layer in AD than in FTLD. In the cortical regions, the 2 pathological groups differed only in frontal white matter, with the FTLD group showing higher microglial scores. FTLD showed higher microglial activation in the white matter compared to the respective gray matter in the entorhinal, temporal, and frontal regions. Conclusions: Our work expands the knowledge of the distribution and magnitude of microglial activation in these disorders. Additionally, we found some microglial circuit-specific patterns that could help to explain some of the clinical overlap between AD and FTLD-TDP, namely in memory deficits. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
6. Heterogeneous ribonuclear protein A3 (hnRNP A3) is present in dipeptide repeat protein containing inclusions in Frontotemporal Lobar Degeneration and Motor Neurone disease associated with expansions in C9orf72 gene.
- Author
-
Davidson, Yvonne S., Flood, Louis, Robinson, Andrew C., Yoshihiro Nihei, Mori, Kohji, Rollinson, Sara, Richardson, Anna, Benson, Bridget C., Jones, Matthew, Snowden, Julie S., Pickering-Brown, Stuart, Haass, Christian, Lashley, Tammaryn, and Mann, David M. A.
- Subjects
FRONTOTEMPORAL lobar degeneration ,GENETICS of amyotrophic lateral sclerosis ,GENETIC mutation ,GENETICS - Abstract
Frontotemporal Lobar Degeneration (FTLD) encompasses certain related neurodegenerative disorders which alter behaviour, personality and language. Heterogeneous ribonuclear proteins (hnRNPs) maintain RNA metabolism and changes in their function may underpin the pathogenesis of FTLD. Immunostaining for hnRNP A1, A2/B1 and A3 was performed on sections of temporal cortex with hippocampus from 61 patients with FTLD, stratified by pathological hallmarks into FTLD-tau and FTLD-TDP type A, B and C subtypes, and by genetics into patients with C9orf72 expansions, MAPT or GRN mutations, or those without known mutation. Four patients with Motor Neurone Disease (MND) with C9orf72 expansions and 10 healthy controls were also studied. Semi-quantitative analysis assessed hnRNP staining intensity in dentate gyrus (DG) and CA4 region of hippocampus, and temporal cortex (Tcx) in the different pathological and genetic groups. Immunostaining for hnRNP A1, A2/B1 and A3 revealed no consistent changes in pattern or amount of physiological staining across any of the pathological or genetic groups. No immunostaining of any inclusions resembling TDP-43 immunoreactive neuronal cytoplasmic inclusions or dystrophic neurites, was seen in either Tcx or DG of the hippocampus in any of the FTLD cases investigated for hnRNP A1, A2/B1 and A3. However, immunostaining for hnRNP A3 showed that inclusion bodies, resembling those TDP-43 negative, p62-immunopositive structures containing dipeptide repeat proteins (DPR) were variably observed in hippocampus and cerebellum. The proportion of cases showing hnRNP A3-immunoreactive DPR, and the number of hnRNP A3-positive inclusions within cases, was significantly greater in DG than in cells of CA4 region and cerebellum, but the latter was significantly less in all three regions compared to that detected by p62 immunostaining. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
7. Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tau.
- Author
-
Taniguchi-Watanabe, Sayuri, Arai, Tetsuaki, Kametani, Fuyuki, Nonaka, Takashi, Masuda-Suzukake, Masami, Tarutani, Airi, Murayama, Shigeo, Saito, Yuko, Arima, Kunimasa, Yoshida, Mari, Akiyama, Haruhiko, Robinson, Andrew, Mann, David, Iwatsubo, Takeshi, and Hasegawa, Masato
- Subjects
NEURODEGENERATION ,ALZHEIMER'S disease research ,FRONTOTEMPORAL lobar degeneration ,IMMUNOBLOTTING ,AMINO acid sequence ,MASS spectrometry - Abstract
Intracellular filamentous tau pathology is the defining feature of tauopathies, which form a subset of neurodegenerative diseases. We have analyzed pathological tau in Alzheimer's disease, and in frontotemporal lobar degeneration associated with tauopathy to include cases with Pick bodies, corticobasal degeneration, progressive supranuclear palsy, and ones due to intronic mutations in MAPT. We found that the C-terminal band pattern of the pathological tau species is distinct for each disease. Immunoblot analysis of trypsin-resistant tau indicated that the different band patterns of the 7-18 kDa fragments in these diseases likely reflect different conformations of tau molecular species. Protein sequence and mass spectrometric analyses revealed the carboxyl-terminal region (residues 243-406) of tau comprises the protease-resistant core units of the tau aggregates, and the sequence lengths and precise regions involved are different among the diseases. These unique assembled tau cores may be used to classify and diagnose disease strains. Based on these results, we propose a new clinicopathological classification of tauopathies based on the biochemical properties of tau. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
8. Accumulation of dipeptide repeat proteins predates that of TDP-43 in frontotemporal lobar degeneration associated with hexanucleotide repeat expansions in C9ORF72 gene.
- Author
-
Baborie, Atik, Griffiths, Timothy D., Jaros, Evelyn, Perry, Robert, McKeith, Ian G., Burn, David J., Masuda-Suzukake, Masami, Hasegawa, Masato, Rollinson, Sara, Pickering-Brown, Stuart, Robinson, Andrew C., Davidson, Yvonne S., and Mann, David M. A.
- Subjects
FRONTOTEMPORAL lobar degeneration ,AMYOTROPHIC lateral sclerosis ,DIPEPTIDES ,C9ORF72 gene ,POLYMERASE chain reaction methodology ,BRONCHOPNEUMONIA - Abstract
Aims Frontotemporal lobar degeneration ( FTLD) and motor neurone disease are linked by the possession of a hexanucleotide repeat expansion in C9ORF72, and both show neuronal cytoplasmic inclusions within cerebellar and hippocampal neurones which are TDP-43 negative but immunoreactive for p62 and dipeptide repeat proteins ( DPR), these being generated by a non- ATG RAN translation of the expanded region of the gene. Methods Twenty-two cases of FTLD from Newcastle were analysed for an expansion in C9ORF72 by repeat primed PCR and Southern blot. Detailed case note analysis was performed, and blinded retrospective clinical impressions were achieved by review of clinical histories. Sections from all major brain regions were immunostained for TDP-43, p62 and DPR. The extent of TDP-43 and DPR pathology in expansion bearers was compared with that in 13 other previously identified cases from the Manchester Brain Bank with established disease. Results Three Newcastle patients bearing an expansion in C9ORF72 were identified. These three patients died prematurely, two from bronchopneumonia within 10 months and 3 years of onset, and one from myocardial infarction 3 years after onset. In all three, DPR were plentiful throughout all cerebral cortical regions, hippocampus and cerebellum, but TDP-43 pathological changes were sparse. The severity of DPR pathological changes in these three patients was similar to that in the Manchester series, although the extent of TDP-43 pathology was significantly less. Conclusion Widespread accumulation of DPR within nerve cells may occur much earlier than that of TDP-43 in patients with FTLD bearing expansion in C9ORF72. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
9. Histone deacetylases ( HDACs) in frontotemporal lobar degeneration.
- Author
-
Whitehouse, Amy, Doherty, Klara, Yeh, Hsin Hsien, Robinson, Andrew C., Rollinson, Sara, Pickering‐Brown, Stuart, Snowden, Julie, Thompson, Jennifer C, Davidson, Yvonne S., and Mann, David M. A.
- Subjects
HISTONE deacetylase ,NEURODEGENERATION ,IMMUNOSTAINING ,DENTATE gyrus ,NEUROLOGICAL disorders - Abstract
Aims Frontotemporal lobar degeneration ( FTLD) is clinically and pathologically heterogeneous. Although associated with variations in MAPT, GRN and C9ORF72, the pathogenesis of these, and of other nongenetic, forms of FTLD, remains unknown. Epigenetic factors such as histone regulation by histone deacetylases ( HDAC) may play a role in the dysregulation of transcriptional activity, thought to underpin the neurodegenerative process. Methods The distribution and intensity of HDACs 4, 5 and 6 was assessed semi-quantitatively in immunostained sections of temporal cortex with hippocampus, and cerebellum, from 33 pathologically confirmed cases of FTLD and 27 controls. Results We found a significantly greater intensity of cytoplasmic immunostaining for HDAC4 and HDAC6 in granule cells of the dentate gyrus in cases of FTLD overall compared with controls, and specifically in cases of FTLD tau- Picks compared with FTLD tau- MAPT and controls. No differences were noted between FTLD- TDP subtypes, or between the different genetic and nongenetic forms of FTLD. No changes were seen in HDAC5 in any FTLD or control cases. Conclusions Dysregulation of HDAC4 and/or HDAC6 could play a role in the pathogenesis of FTLD-tau associated with Pick bodies, although their lack of immunostaining implies that such changes do not contribute directly to the formation of Pick bodies. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
10. No interaction between tau and TDP-43 pathologies in either frontotemporal lobar degeneration or motor neurone disease.
- Author
-
Robinson, Andrew C., Thompson, Jennifer C., Weedon, Lindsey, Rollinson, Sara, Pickering‐Brown, Stuart, Snowden, Julie S., Davidson, Yvonne S., and Mann, David M. A.
- Subjects
- *
FRONTOTEMPORAL dementia , *FRONTOTEMPORAL lobar degeneration , *MOTOR neuron diseases , *GENETIC mutation , *NUCLEOTIDES , *PATHOLOGY , *ALZHEIMER'S disease - Abstract
Introduction Frontotemporal lobar degeneration ( FTLD) is classified mainly into FTLD-tau and FTLD- TDP according to the protein present within inclusion bodies. While such a classification implies only a single type of protein should be present, recent studies have demonstrated dual tau and TDP-43 proteinopathy can occur, particularly in inherited FTLD. Methods We therefore investigated 33 patients with FTLD-tau (including 9 with MAPT mutation) for TDP-43 pathological changes, and 45 patients with FTLD- TDP (including 12 with hexanucleotide expansion in C9ORF72 and 12 with GRN mutation), and 23 patients with motor neurone disease (3 with hexanucleotide expansion in C9ORF72), for tauopathy. Results TDP-43 pathological changes, of the kind seen in many elderly individuals with Alzheimer's disease, were seen in only two FTLD-tau cases - a 70-year-old male with exon 10 + 13 mutation in MAPT, and a 73-year-old female with corticobasal degeneration. Such changes were considered to be secondary and probably reflective of advanced age. Conversely, there was generally only scant tau pathology, usually only within hippocampus and/or entorhinal cortex, in most patients with FTLD- TDP or MND. The extent of tau pathology in FTLD- TDP and MND, as with amyloid β protein, may relate to increased age and possession of Apolipoprotein ε4 allele. Conclusion We find no predilection or predisposition towards an accompanying TDP-43 pathology in patients with FTLD-tau, irrespective of presence or absence of MAPT mutation, or that genetic changes associated with FTLD- TDP predispose towards excessive tauopathy. Where the two processes coexist, this is limited and probably causatively independent of each other. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
11. Patterns of microglial cell activation in frontotemporal lobar degeneration.
- Author
-
Lant, Suzannah B., Robinson, Andrew C., Thompson, Jennifer C., Rollinson, Sara, Pickering‐Brown, Stuart, Snowden, Julie S., Davidson, Yvonne S., Gerhard, Alexander, and Mann, David M. A.
- Subjects
- *
FRONTOTEMPORAL dementia , *DEGENERATION (Pathology) , *IMMUNOHISTOCHEMISTRY , *PATHOLOGICAL psychology , *ALZHEIMER'S disease - Abstract
Aims Pathological heterogeneity within patients with frontotemporal lobar degeneration ( FTLD) in general precludes the accurate assignment of diagnostic subtype in life. The aim of this study was to assess the extent of microglial cell activation in FTLD in order to determine whether it might be possible to employ this as a diagnostic marker in vivo using PET ligand [11 C]( R)- PK11195 in order to differentiate cases of FTLD according to histological subtype. Methods The distribution and extent of microglial cell activation was assessed semi-quantitatively in cortical grey and subcortical white matter of CD68 immunostained sections of frontal and temporal cortex from 78 pathologically confirmed cases of FTLD, 13 of Alzheimer's disease ( AD) and 13 controls. Results Significantly higher levels of microglial cell activation than controls occurred in all four regions in FTLD, and in three of the four regions in AD. Microglial activation was greater in frontal subcortical white matter in FTLD than AD, whereas it was higher in temporal cortical grey matter in AD than FTLD. Microglial cell activation was significantly higher in temporal subcortical white matter in FTLD- MAPT than in other genetic ( GRN, C9ORF 72) or non-genetic forms of FTLD. Conclusions The present study suggests that high levels of microglial cell involvement in temporal lobe (subcortical white matter) might serve as a marker of inherited FTLD associated with intronic mutations in MAPT, with a relatively intense signal in this region in PET studies using [11 C]( R)- PK11195 as microglial cell marker could indicate the presence of MAPT mutation in vivo. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
12. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations.
- Author
-
Snowden, Julie S., Rollinson, Sara, Thompson, Jennifer C., Harris, Jennifer M., Stopford, Cheryl L., Richardson, Anna M. T., Jones, Matthew, Gerhard, Alex, Davidson, Yvonne S., Robinson, Andrew, Gibbons, Linda, Hu, Quan, DuPlessis, Daniel, Neary, David, Mann, David M. A., and Pickering-Brown, Stuart M.
- Subjects
FRONTOTEMPORAL dementia ,NEUROLOGICAL disorders ,PSYCHOSES ,MOTOR neuron diseases ,GENETICS ,CHROMOSOMES ,GENETIC mutation - Abstract
The identification of a hexanucleotide repeat expansion in the C9ORF72 gene as the cause of chromosome 9-linked frontotemporal dementia and motor neuron disease offers the opportunity for greater understanding of the relationship between these disorders and other clinical forms of frontotemporal lobar degeneration. In this study, we screened a cohort of 398 patients with frontotemporal dementia, progressive non-fluent aphasia, semantic dementia or mixture of these syndromes for mutations in the C9ORF72 gene. Motor neuron disease was present in 55 patients (14%). We identified 32 patients with C9ORF72 mutations, representing 8% of the cohort. The patients’ clinical phenotype at presentation varied: nine patients had frontotemporal dementia with motor neuron disease, 19 had frontotemporal dementia alone, one had mixed semantic dementia with frontal features and three had progressive non-fluent aphasia. There was, as expected, a significant association between C9ORF72 mutations and presence of motor neuron disease. Nevertheless, 46 patients, including 22 familial, had motor neuron disease but no mutation in C9ORF72. Thirty-eight per cent of the patients with C9ORF72 mutations presented with psychosis, with a further 28% exhibiting paranoid, deluded or irrational thinking, whereas <4% of non-mutation bearers presented similarly. The presence of psychosis dramatically increased the odds that patients carried the mutation. Mutation bearers showed a low incidence of motor stereotypies, and relatively high incidence of complex repetitive behaviours, largely linked to patients’ delusions. They also showed a lower incidence of acquired sweet food preference than patients without C9ORF72 mutations. Post-mortem pathology in five patients revealed transactive response DNA-binding protein 43 pathology, type A in one patient and type B in three. However, one patient had corticobasal degeneration pathology. The findings indicate that C9ORF72 mutations cause some but not all cases of frontotemporal dementia with motor neuron disease. Other mutations remain to be discovered. C9ORF72 mutations are associated with variable clinical presentations and pathology. Nevertheless, the findings highlight a powerful association between C9ORF72 mutations and psychosis and suggest that the behavioural characteristics of patients with C9ORF72 mutations are qualitatively distinct. Mutations in the C9ORF72 gene may be a major cause not only of frontotemporal dementia with motor neuron disease but also of late onset psychosis. [ABSTRACT FROM PUBLISHER]
- Published
- 2012
- Full Text
- View/download PDF
13. Plasma levels of progranulin and interleukin-6 in frontotemporal lobar degeneration.
- Author
-
Gibbons, Linda, Rollinson, Sara, Thompson, Jennifer C., Robinson, Andrew, Davidson, Yvonne S., Richardson, Anna, Neary, David, Pickering-Brown, Stuart M., Snowden, Julie S., and Mann, David M.A.
- Subjects
- *
BLOOD plasma , *PROGRANULIN , *INTERLEUKIN-6 , *FRONTOTEMPORAL lobar degeneration , *BIOMARKERS , *ETIOLOGY of diseases - Abstract
We have measured plasma progranulin and interleukin-6 in 230 patients with frontotemporal lobar degeneration (FTLD), 104 patients with Alzheimer's disease, and 161 control subjects. We have replicated previous findings of decreased levels of progranulin protein in FTLD because of mutations in GRN and show this is not observed in FTLD cases because of other causes. interleukin-6 levels were increased in FTLD overall, but these did not discriminate between clinical and genetic subtypes. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
14. Analysis of the hexanucleotide repeat in C9ORF72 in Alzheimer's disease
- Author
-
Rollinson, Sara, Halliwell, Nicola, Young, Kate, Callister, Janis Bennion, Toulson, Greg, Gibbons, Linda, Davidson, Yvonne S., Robinson, Andrew C., Gerhard, Alex, Richardson, Anna, Neary, David, Snowden, Julie, Mann, David M.A., and Pickering-Brown, Stuart M.
- Subjects
- *
ALZHEIMER'S disease , *FRONTOTEMPORAL dementia , *AMYOTROPHIC lateral sclerosis , *COHORT analysis , *NEURODEGENERATION , *MOTOR neuron diseases - Abstract
Abstract: Frontotemporal lobar degeneration (FTLD) is a highly familial neurodegenerative disease. It has recently been shown that the most common genetic cause of FTLD and amyotrophic lateral sclerosis (ALS) is a hexanucleotide repeat expansion in C9ORF72. To investigate whether this expansion was specific to the FTLD/ALS disease spectrum, we genotyped the hexanucleotide repeat region of C9ORF72 in a large cohort of patients with Alzheimer''s disease (AD). A normal range of repeats was found in all cases. We conclude that the hexanucleotide repeat expansion is specific to the FTLD/ALS disease spectrum. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.